Hong J, Park K, Kim J, Hwang W, Lim D.  Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease.  JOMES 2020;29:215-221.  https://doi.org/10.7570/jomes20040